Saturday, April 6, 2019
IGCS PARSGO JOINED SYMPOSIUM
Chair: T. Herzog, A. Poveda, J. Sehouli
How to Motivate Patients for Clinical Trials
What are the Best Designs for Clinical Trials with Targeted Therapies?
How to Interpret Data Trials in Rare Tumors
Current and Future Aspects in Cervical Screening
The Turkish Experience: M. Gultekin
Global Perspectives: A. Kaufmann
JOINED SYMPOSIUM: TOC, ENGOT, EUTROC, INTEGRATE
Block I: Tailored Treatment of Ovarian Cancer
Chair: E. I. Braicu, N. Concin
Early Stages: Is There a Signature that Can Predict Relapse?
M. Birrer, H. Kulbe
Can we Predict Response to Anti-Angiogenetic Drugs?
Understanding PARPi Sensitivity or Addressing Platinum Sensitivity
A. E. Wahner-Hendrickson
Is there a Signature for Long-Term Survival with Ovarian Cancer?
Lunch Break + Poster Session
Block II: Evidence Based and Personalized Medicine – Complementary Approaches?
Chair: C. Kolberg-Liedtke, C. Gourley
Chances and Limits of Next Generation Sequencing for Treatment Decision
What are the Clinical Consequences of Tumor Profiling in Gynecological Oncology?
Early Recognition of Therapy Resistance by Patient Reported Outcome
Role of PARP Therapies in Breast Cancer
Modifiers of Endocrine Resistance like CDK4/6 and PiK3CA Inhibitors: Who Benefits?
The Microbiome in Prediction of Cancer Therapy Response
Presentation of the Three Best Posters Closing Words and Farewell
J.-U. Blohmer, W. A. Cliby, J. Sehouli
9.00 am to 11.00 am · parallel to main program
INTENSIVE WORKSHOP CERVICAL CANCER
The Current Aspects of Cervical Cancer Therapy
Early Cervical Cancer: How to Modify the Radicality?
A Sentinel Lymph Node Mapping Algorithm
N. R. Abu Rustum
Nerve Sparing Radical Hysterectomy: Why? And Who are the Candidates?
M. Z. Muallem
limited number of participants · extra charge · only in combination with a conference ticket